Susan Hohenleitner - 04 Nov 2025 Form 3 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Financial Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Susan Hohenleitner
Issuer symbol
ARDX
Transactions as of
04 Nov 2025
Net transactions value
$0
Form type
3
Filing time
07 Nov 2025, 16:04:50 UTC
Next filing
26 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hohenleitner Susan Chief Financial Officer C/O ARDELYX, INC., 400 FIFTH AVE, SUITE 210, WALTHAM /s/ Elizabeth Grammer, Attorney-in-Fact for Susan Hohenleitner 07 Nov 2025 0002093095

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ARDX Common Stock 146,896 04 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ARDX Stock Option (Right to Buy) 04 Nov 2025 Common Stock 578,104 $5.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.
F2 Twenty Five Percent (25%) of the shares subject to the option vest on October 13, 2026 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney